TY - JOUR
T1 - Trends in sales of sugar-sweetened beverages and associated type 2 diabetes burden in nine African countries
T2 - an ecological time-series analysis
AU - Karugu, Caroline H.
AU - Asiki, Gershim
AU - Mthembu, Senzo
AU - Iddi, Samuel
AU - Kaberia, Peter M.
AU - Mohamed, Shukri F.
AU - Sanya, Richard E.
AU - Kiwuwa-Muyingo, Sylvia
AU - Vandevijvere, Stefanie
AU - Agyemang, Charles
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2025
Y1 - 2025
N2 - Background: Sugar-sweetened beverages (SSBs) are recognized contributors to the global rise in non-communicable diseases. While the link between SSB intake and adverse health outcomes is well established, long-term data from African countries are limited. Objective: To assess trends in SSB sales and their associations with type 2 diabetes (T2D) burden across nine African countries from 2010 to 2024. Methods: We conducted an ecological time-series analysis using national-level data from Cameroon, Côte d’Ivoire, Ethiopia, Ghana, Kenya, Morocco, Nigeria, South Africa, and Uganda. Annual changes in per capita and total SSB sales, national T2D prevalence, and the number of adults with T2D were analyzed. Country-specific multivariate Vector Autoregressive (MVAR) models estimated associations between SSB sales and T2D outcomes. Results: SSB sales rose across all countries, with the sharpest per capita increases in Cameroon (+173.8%), Nigeria (+119.1%), and Côte d’Ivoire (+88.5%). T2D trends varied: Ethiopia, Morocco, and South Africa showed rising prevalence and case numbers, while Ghana and Nigeria showed declines. Per capita SSB sales were significantly associated with adult T2D burden in Ghana (β = 0.41, p = 0.005) and Ethiopia (β = 0.37, p = 0.039. Total SSB volume was associated with T2D burden in Kenya (β = 0.49, p = 0.046) and with T2D prevalence in Nigeria, Morocco, and Côte d’Ivoire. Conclusions: Rising SSB sales may be contributing to the T2D burden in African countries. This calls for context-specific regulatory measures, such as fiscal taxes and front-of-pack labels.
AB - Background: Sugar-sweetened beverages (SSBs) are recognized contributors to the global rise in non-communicable diseases. While the link between SSB intake and adverse health outcomes is well established, long-term data from African countries are limited. Objective: To assess trends in SSB sales and their associations with type 2 diabetes (T2D) burden across nine African countries from 2010 to 2024. Methods: We conducted an ecological time-series analysis using national-level data from Cameroon, Côte d’Ivoire, Ethiopia, Ghana, Kenya, Morocco, Nigeria, South Africa, and Uganda. Annual changes in per capita and total SSB sales, national T2D prevalence, and the number of adults with T2D were analyzed. Country-specific multivariate Vector Autoregressive (MVAR) models estimated associations between SSB sales and T2D outcomes. Results: SSB sales rose across all countries, with the sharpest per capita increases in Cameroon (+173.8%), Nigeria (+119.1%), and Côte d’Ivoire (+88.5%). T2D trends varied: Ethiopia, Morocco, and South Africa showed rising prevalence and case numbers, while Ghana and Nigeria showed declines. Per capita SSB sales were significantly associated with adult T2D burden in Ghana (β = 0.41, p = 0.005) and Ethiopia (β = 0.37, p = 0.039. Total SSB volume was associated with T2D burden in Kenya (β = 0.49, p = 0.046) and with T2D prevalence in Nigeria, Morocco, and Côte d’Ivoire. Conclusions: Rising SSB sales may be contributing to the T2D burden in African countries. This calls for context-specific regulatory measures, such as fiscal taxes and front-of-pack labels.
KW - ecological analysis
KW - non-communicable diseases
KW - sugar-sweetened beverages
KW - type 2 diabetes
KW - ultra-processed foods
UR - https://www.scopus.com/pages/publications/105018283471
U2 - 10.1080/16549716.2025.2568283
DO - 10.1080/16549716.2025.2568283
M3 - Article
C2 - 41065711
AN - SCOPUS:105018283471
SN - 1654-9880
VL - 18
JO - Global Health Action
JF - Global Health Action
IS - 1
M1 - 2568283
ER -